Agree that galidesivir looks 1000x more promising than remdesivir... Similar problem: why weren't they given more support for testing in the US... thousands of patients enrolled into remd and hydroxy trials...

Anyway, it would be screaming injustice if we don't get some $$$ for our current and future (long-haulers) trials... But in the best case, we get an EUA soon and don't need it anyway...